{"title":"新冠肺炎治疗进展及疫苗研制综述","authors":"V. P. Sonar, Priyanka V Dalvi, S. Chalikwar","doi":"10.46624/ajptr.2021.v11.i4.005","DOIUrl":null,"url":null,"abstract":"The entire world is facing a worst situation of pandemic ever. It’s been more than 18 months \nafter the initial reports on Covid from China, and the pandemic is still going. As per the data \navailable over the WHO website as of 23 June 2021, there have been 178,837,204 confirmed \ncases of COVID-19, including 3,880,450 deaths, reported to WHO. As of 21 June 2021, a total \nof 2,414,347,324 vaccine doses have been administered. Despite of having more than 15 \nvaccines for Covid-19; the challenge to treat a patient with a define line of treatment remains the \nsame. In the present review we have made an attempt to summarize the various medicines which \nare being used by medical practitioner in India and overseas. Use of different drug molecules like \nRemdesivir, Tocilzumab, Hydroxychloroquine, Azithromycine, Ivermectin, Steroids, \nDoxicycline, Ecosprine, Low molecular weight Heparin, Lopinavir and Ritonavir, Nitazoxanide, \nBaricitinib etc. were highlighted; although the list is long. A focus is made on the different types \nof vaccines available till date and their status in various countries. \nKeywords: Covid-19, Vaccine, Antiviral, Pandemic, Antibiotics.","PeriodicalId":7701,"journal":{"name":"American Journal of PharmTech Research","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Progress and Development in Treatment of Covid – 19, and Vaccine development: A Review\",\"authors\":\"V. P. Sonar, Priyanka V Dalvi, S. Chalikwar\",\"doi\":\"10.46624/ajptr.2021.v11.i4.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The entire world is facing a worst situation of pandemic ever. It’s been more than 18 months \\nafter the initial reports on Covid from China, and the pandemic is still going. As per the data \\navailable over the WHO website as of 23 June 2021, there have been 178,837,204 confirmed \\ncases of COVID-19, including 3,880,450 deaths, reported to WHO. As of 21 June 2021, a total \\nof 2,414,347,324 vaccine doses have been administered. Despite of having more than 15 \\nvaccines for Covid-19; the challenge to treat a patient with a define line of treatment remains the \\nsame. In the present review we have made an attempt to summarize the various medicines which \\nare being used by medical practitioner in India and overseas. Use of different drug molecules like \\nRemdesivir, Tocilzumab, Hydroxychloroquine, Azithromycine, Ivermectin, Steroids, \\nDoxicycline, Ecosprine, Low molecular weight Heparin, Lopinavir and Ritonavir, Nitazoxanide, \\nBaricitinib etc. were highlighted; although the list is long. A focus is made on the different types \\nof vaccines available till date and their status in various countries. \\nKeywords: Covid-19, Vaccine, Antiviral, Pandemic, Antibiotics.\",\"PeriodicalId\":7701,\"journal\":{\"name\":\"American Journal of PharmTech Research\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of PharmTech Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46624/ajptr.2021.v11.i4.005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of PharmTech Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46624/ajptr.2021.v11.i4.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Progress and Development in Treatment of Covid – 19, and Vaccine development: A Review
The entire world is facing a worst situation of pandemic ever. It’s been more than 18 months
after the initial reports on Covid from China, and the pandemic is still going. As per the data
available over the WHO website as of 23 June 2021, there have been 178,837,204 confirmed
cases of COVID-19, including 3,880,450 deaths, reported to WHO. As of 21 June 2021, a total
of 2,414,347,324 vaccine doses have been administered. Despite of having more than 15
vaccines for Covid-19; the challenge to treat a patient with a define line of treatment remains the
same. In the present review we have made an attempt to summarize the various medicines which
are being used by medical practitioner in India and overseas. Use of different drug molecules like
Remdesivir, Tocilzumab, Hydroxychloroquine, Azithromycine, Ivermectin, Steroids,
Doxicycline, Ecosprine, Low molecular weight Heparin, Lopinavir and Ritonavir, Nitazoxanide,
Baricitinib etc. were highlighted; although the list is long. A focus is made on the different types
of vaccines available till date and their status in various countries.
Keywords: Covid-19, Vaccine, Antiviral, Pandemic, Antibiotics.